Managing gastrotoxicities for RCC treatment – Gastroenterologist's perspective
Managing gastrotoxicities for RCC treatment – Gastroenterologist's perspective
WRN inhibitor shows promise in patients with MSI and/or dMMR advanced solid tumours
Olaparib plus pembrolizumab shows promising results in BRCA mutated cancers
A conversational artificial intelligence system enhances precision medicine and health equity
Metastasis-directed radiotherapy shows good prognosis for oligometastatic kidney cancer
Penpulimab in combination with chemotherapy for metastatic nasopharyngeal cancer shows positive results
Addition of pembrolizumab to standard care shows promising results in advanced head and neck cancer
EGFR shows to be a promising therapeutic target in NF1 mutant melanoma
ELCC 2025: Latest in EGFR positive NSCLC
Understanding AL amyloidosis: Treatment and diagnosis
Addressing challenges in palliative care
Advances in multiple myeloma treatment in the Philippines